Redeye remains positive to ADDvise following a stable quarter, where particularly Labs improved its EBITDA significantly YoY. Management seems optimistic regarding both demand and M&A activity, and the net debt is now at a healthy level. We leave our Base case and forecast unchanged while noting Q1 as another solid quarter.